Michael Oberdorfer Posted June 6, 2019 Share Posted June 6, 2019 The Washington Post and other news sources report on a change of HHS policy which effectively bans all government-funded human fetal tissue research on material obtained from elective abortions. The policy change will terminate NIH intramural, extramural and a long-standing partnership between the University of California San Francisco and NIH to research and design animal models for vaccine development and a range of diseases including neurodegenerative conditions. You can see the UCSF response here. The Post reports this policy shift appears to be politically motivated involving the Vice President and announced yesterday by the President. The announcement has sparked wide condemnation throughout the research community, including a statement by Doug Melton, a professor at Harvard: “The regulatory and legal framework in the U.S. for overseeing fetal tissue research was carefully developed with input from the public, ethicists, policymakers and scientists and ensures rigorous oversight, including that the tissue is obtained legally and with donor consent.” Other researchers have said at present there are no effective alternatives to this human fetal tissue research although work is underway in this area. Your thoughts, and how will this affect your research. Link to comment Share on other sites More sharing options...
Please sign in to comment
You will be able to leave a comment after signing in